89bio Inc.

8.03
-0.93 (-10.38%)
At close: Mar 28, 2025, 3:58 PM
8.00
-0.37%
After-hours: Mar 28, 2025, 04:58 PM EDT

89bio Income Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18
Revenue n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue n/a 273K 240K 79K 60K 17K 6K
Gross Profit n/a -273K -240K -79K -60K -17K -6K
Operating Income -384.66M -151.2M 102.25M -89.74M -49.35M -26.64M -15.16M
Interest Income n/a n/a 2.16M 148K n/a n/a n/a
Pretax Income -366.39M -138.32M -102.01M -90.27M -49.56M -57.2M -16.15M
Net Income -367.08M -142.19M -102.03M -90.12M -49.5M -57.42M -16.18M
Selling & General & Admin 39.62M 28.97M 21.45M 19.41M 13.16M 5.29M 1.48M
Research & Development 345.04M 122.23M 80.8M 70.33M 36.2M 21.35M 13.68M
Other Expenses n/a n/a 242K -526K -203K -30.56M -986K
Operating Expenses 384.66M 151.2M 102.25M 89.74M 49.35M 26.64M 15.16M
Interest Expense -5.29M 3.59M 1.92M 674K n/a n/a n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses n/a 151.2M 102.25M 89.74M 49.35M 26.64M 15.16M
Income Tax -692K 3.87M 19K -147K -59K 218K 28K
Shares Outstanding (Basic) 104.71M 71.17M 34.81M 20.1M 16.09M 10.64M 4.58M
Shares Outstanding (Diluted) 104.71M 71.17M 34.81M 20.1M 16.09M 10.64M 4.58M
EPS (Basic) -3.51 -2 -2.93 -4.48 -3.08 -5.4 -3.53
EPS (Diluted) -3.51 -2 -2.93 -4.48 -3.08 -5.4 -3.53
EBITDA -384.66M -134.46M -99.84M -90.19M -49.5M -57.19M -16.14M
Depreciation & Amortization n/a 273K 240K 79K 60K 17K 6K